Samik Basu

Chief Scientific Officer

Cabaletta Bio

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Samik Basu serves as the Chief Scientific Officer at Cabaletta Bio in the United States. His research focuses on CAR T therapy applications in autoimmune diseases, including detailed studies on CD19 CAR T therapy and its effects on patients with immune-mediated conditions. Recent publications highlight his work on the specificity and activity of novel anti-CD19 CART therapies, as well as the reactivity profiles of patients with systemic lupus erythematosus following treatment.

Articles (4)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (2)

Christoph Ellebrecht

Hospital of the University of Pennsylvania

UNITED STATES

View details

Sangwook Oh

Assistant Professor

Hallym University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samik Basu

Research Interests

Explore related searches

Contact this professor

About

Articles (4)

Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial.

Preclinical specificity & activity of a fully human 41BB-expressing anti-CD19 CART- therapy for treatment-resistant autoimmune disease.

Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy.

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.

Collaborators (2)

Christoph Ellebrecht

Sangwook Oh

Make your next move.